{"id":315409,"date":"2020-01-31T15:00:01","date_gmt":"2020-01-31T23:00:01","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/01\/healthcare-roundup-european-advisory-backs-new-labeling-for-two-abbvie-meds-merck-withdraws-keytruda-application\/"},"modified":"2020-01-31T16:40:48","modified_gmt":"2020-02-01T00:40:48","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89%e6%ac%a7%e6%b4%b2%e5%92%a8%e8%af%a2%e6%9c%ba%e6%9e%84%e6%94%af%e6%8c%81%e4%b8%a4%e7%a7%8d%e8%89%be%e4%bc%af%e7%bb%b4%e8%8d%af%e5%93%81%e9%80%82","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2020\/01\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89%e6%ac%a7%e6%b4%b2%e5%92%a8%e8%af%a2%e6%9c%ba%e6%9e%84%e6%94%af%e6%8c%81%e4%b8%a4%e7%a7%8d%e8%89%be%e4%bc%af%e7%bb%b4%e8%8d%af%e5%93%81%e9%80%82\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014\u6b27\u6d32\u54a8\u8be2\u673a\u6784\u652f\u6301\u4e24\u79cd\u827e\u4f2f\u7ef4\u836f\u54c1\u9002\u5e94\u75c7\uff0c\u9ed8\u514b\u64a4\u56deKeytruda\u6cbb\u7597\u98df\u9053\u764c\u7533\u8bf7"},"content":{"rendered":"<h2>\u6b27\u6d32\u54a8\u8be2\u673a\u6784\u652f\u6301\u4e24\u79cd\u827e\u4f2f\u7ef4\u836f\u54c1\u9002\u5e94\u75c7\uff1b\u80a1\u4ef7\u4e0a\u6da81%<\/h2>\n<ul>\n<li>\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\u7684\u54a8\u8be2\u5c0f\u7ec4CHMP\u91c7\u7eb3\u4e86\u79ef\u6781\u610f\u89c1\uff0c\u5efa\u8bae\u6269\u5927<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ABBV\">\u827e\u4f2f\u7ef4\uff08NYSE\uff1aABBV\uff09<\/a>\u827e\u6ecb\u836f\u7269Maviret\uff08glecaprevir \/ pibrentasvir\uff09\u548c\u8840\u6db2\u764c\u836f\u7269venclyxto\uff08venetoclax\uff09\u7684\u9002\u5e94\u75c7\u3002<\/li>\n<li>Maviret\uff1a\u5c06\u521d\u6cbb\uff0c\u4ee3\u507f\u6027\u57fa\u56e0\u578b3\u7684\u809d\u786c\u5316\u60a3\u8005\u7684\u6cbb\u7597\u65f6\u95f4\u4ece12\u5468\u7f29\u77ed\u52308\u5468\u3002<\/li>\n<li>Venclyxto\uff1a\u7528\u4e8e\u4ee5\u524d\u672a\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u6027\u767d\u8840\u75c5\u7684\u6210\u4eba\uff0c\u4e0eobinutuzumab\uff08\u7f57\u6c0f\u7684Gazyva\uff09\u8054\u5408\u4f7f\u7528\u3002<\/li>\n<li>\u76d8\u524d\u80a1\u4ef7\u4e0a\u6da81%\u3002<\/li>\n<\/ul>\n<h2>\u9ed8\u514b\u64a4\u56deKeytruda\u6cbb\u7597\u98df\u9053\u764c\u7533\u8bf7<\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=MRK\">\u9ed8\u514b\u516c\u53f8(NYSE:MRK)<\/a>\u5df2\u64a4\u56de\u5728\u6b27\u6d32\u5bfb\u6c42\u6279\u51c6\u4f7f\u7528Keytruda\u6cbb\u7597\u98df\u9053\u764c\u7684\u9500\u7533\u8bf7\u3002\u6b27\u6d32\u836f\u76d1\u5c40\u786e\u5b9a\u652f\u6301\u8be5\u7533\u8bf7\u7684\u6570\u636e\u4e0d\u8db3\u4ee5\u8bc1\u660e\u6cbb\u7597\u5ef6\u957f\u4e86\u751f\u5b58\u671f\u3002<\/li>\n<\/ul>\n<h2>\u5f3a\u751f\u9762\u4e34\u9ad8\u8fbe3.44\u4ebf\u7f8e\u5143\u7684\u8d54\u507f<\/h2>\n<ul>\n<li>\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u68c0\u5bdf\u957f\u8d1d\u7ef4\u5c14\uff08Xavier Becerra\uff09\u5728\u4e00\u4efd\u58f0\u660e\u4e2d\u8bf4\uff1a\u201c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=JNJ\">\u5f3a\u751f\u516c\u53f8\uff08NYSE\uff1aJNJ\uff09<\/a>\u77e5\u9053\u5176\u7f51\u72b6\u4ea7\u54c1\u7684\u5371\u9669\uff0c\u4f46\u4ecd\u4ee5\u5229\u6da6\u4e3a\u5148\uff0c\u4e0d\u987e\u6570\u4ee5\u767e\u4e07\u8ba1\u5973\u6027\u7684\u5065\u5eb7\u201d\u3002<\/li>\n<li>\u8be5\u4ea7\u54c1\u4e5f\u79f0\u4e3a\u7ecf\u9634\u9053\u7f51\u72b6\uff0c\u662f\u901a\u8fc7\u5916\u79d1\u624b\u672f\u7ecf\u9634\u9053\u690d\u5165\u7684\u5408\u6210\u6750\u6599\uff0c\u8fd9\u4e9b\u5973\u6027\u7684\u9aa8\u76c6\u5668\u5b98\u4e0b\u5782\u6216\u5728\u54b3\u55fd\u3001\u6253\u55b7\u568f\u6216\u4e3e\u8d77\u91cd\u7269\u65f6\u60a3\u6709\u538b\u529b\u6027\u5c3f\u5931\u7981\u3002<\/li>\n<li>\u8be5\u88c1\u51b3\u53d1\u5e03\u4e4b\u9645\uff0c\u5f3a\u751f\u516c\u53f8\u5728\u836f\u7269\u526f\u4f5c\u7528\u3001\u7f8e\u56fd\u963f\u7247\u7c7b\u836f\u7269\u6d41\u884c\u4e2d\u7684\u4f5c\u7528\u4ee5\u53ca\u6709\u5173\u5176\u5a74\u513f\u723d\u8eab\u7c89\u5f15\u8d77\u67d0\u4e9b\u6d88\u8d39\u8005\u60a3\u764c\u7684\u6307\u63a7\u65b9\u9762\u6709\u6570\u5343\u8d77\u5176\u4ed6\u8bc9\u8bbc\u3002<\/li>\n<\/ul>\n<h2>Intec Pharma\u516c\u5f00\u52df\u80a1<\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=NTEC\">Intec Pharma\uff08NASDAQ\uff1aNTEC\uff09<\/a>\u516c\u5f00\u53d1\u884c\u4e861625\u4e07\u80a1\u666e\u901a\u80a1\uff0c\u5e76\u8ba4\u80a1\u6743\u8bc1\u4ee5\u6bcf\u80a10.40\u7f8e\u5143\u7684\u4ef7\u683c\u8d2d\u4e70\u4e86\u76f8\u540c\u6570\u91cf\u7684\u666e\u901a\u80a1\uff0c\u603b\u6536\u76ca\u4e3a650\u4e07\u7f8e\u5143\u3002<\/li>\n<li>\u4e94\u5e74\u671f\u8ba4\u80a1\u6743\u8bc1\u7684\u884c\u4f7f\u4ef7\u4e3a\u6bcf\u80a10.40\u7f8e\u5143\u3002<\/li>\n<\/ul>\n<h2>Arcutis Biotherapeutics\u4e3a\u9996\u6b21\u516c\u5f00\u52df\u80a1\u5b9a\u4ef7<\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ARQT\">Arcutis Biotherapeutics\uff08ARQT\uff09<\/a>\u5df2\u5c06\u5176937.5\u4e07\u80a1\u666e\u901a\u80a1\u7684\u9996\u6b21\u516c\u5f00\u53d1\u884c\u5b9a\u4ef7\u4e3a\u6bcf\u80a117.00\u7f8e\u5143\uff0c\u603b\u6536\u76ca\u7ea6\u4e3a1.594\u4ebf\u7f8e\u5143\u3002<\/li>\n<li>\u9884\u8ba1\u8be5\u80a1\u7968\u5c06\u4e8e\u4eca\u5929\u5728\u7eb3\u65af\u8fbe\u514b\u5168\u7403\u7cbe\u9009\u5e02\u573a\u5f00\u59cb\u4ea4\u6613\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>AbbVie&#8217;s (NYSE:ABBV) HCV med Maviret (glecaprevir\/pibrentasvir) and blood cancer med Venclyxto (venetoclax). Merck withdraws Keytruda application<\/p>\n","protected":false},"author":9,"featured_media":315396,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,925,459],"class_list":["post-315409","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/315409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=315409"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/315409\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/315396"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=315409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=315409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=315409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}